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Summary. — Monitoring of changes at the DNA level enables the characteriza-
tion of the underlying structure of genetic diseases. In particular, copy number
alterations (CNAs) are increasingly being recognized as an important component
of genetic variations in cancer: oncogenes may be enhanced by DNA amplification
and tumor suppressor genes may be inactivated by physical deletion. Encouraged
by the advent of array comparative genomic hybridization technology, several bio-
logical studies have been designed to look for chromosomal aberrations involved in
cancer. Hence, the development of algorithms aimed at the identification of CNAs is
a current challenge in bioinformatics. Despite the amount of proposed approaches,
identification of CNAs is yet an open problem. Here we propose a new approach for
detection of CNAs that extends a previously published algorithm where a popular
image segmentation variational model was used. The proposed algorithm, called
Vega Multi-Channel (VegaMC), starts from the assumption that copy number pro-
files are piecewise constant and finds the optimal segmentation by minimizing a
functional energy that represents a compromise between accuracy and parsimony of
the boundaries. We applied VegaMC on a published gastrointestinal stromal tumor
aCGH dataset, showing the ability of the proposed approach in the identification of
well-known cytogenetic mutations, and eventually discover new ones.
PACS 87.18.Nq – Large-scale biological processes and integrative biophysics.
PACS 87.18.Vf – Systems biology.
PACS 87.85.Ng – Biological signal processing.
1. – Introduction
Chromosomal abnormalities are known to have a direct influence on the development
and progression of genetic diseases as cancer [1]. In the latest years, greater attention
has been paid to CNAs which are defined as genomic regions, larger than 1 kb, in which
copy number differences are observed between two or more genomes [2]. Indeed, it was
observed that oncogenes are often located in regions with a gain in their copy number,
in contrast, oncosuppressor genes are found in lost chromosomal regions. In addition,
copy-neutral loss of heterozygosity (LOH) is receiving greater attention as a mechanism
of possible tumor initiation [3]. Advent of array comparative genomic hybridization
(aCGH) technology has allowed the monitoring of changes at the DNA level for more
than one million of chromosomal loci (probes). In particular, aCGH provides an indirect
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Table I. – List of JS-algorithms.
Algorithm Preprocessing Output Ref.
BSA No Statistical evidence (q-value) [15]
chgMCR Yes None [9]
CNAnova No Statistical evidence (p-value) [18]
GADA No None [16]
GAIA Yes Statistical evidence (q-value) [12]
GISTIC Yes Statistical evidence (q-value) [10]
JISTIC Yes Statistical evidence (q-value) [11]
KCsmart No Statistical evidence (q-value) [17]
pREC-A Yes Probability of alteration [13]
pREC-S Yes Probability of alteration [13]
VegaMC No Weighted mean proposed
measure of copy number for each probe, this measure is known as Log R Ratio (LRR) and
is computed by the ratio of observed to expected hybridization intensities. Supported by
effectiveness of aCGH, several biological studies aimed at the identification of functional
CNAs in cancer have been proposed [4-6]. These studies produced a vast amount of data
that need interpretation, hence a current challenge in bioinformatics is the development of
algorithms to analyze these data. In the literature, we find algorithms that are designed
to provide a map of CNAs of a single genome [7,8] (the so-called segmentation algorithms)
and algorithms that, as VegaMC, look for CNAs shared among the cohort of available
subjects. In this work we focus our attention on this last kind of algorithms that jointly
analyze copy number data from multiple samples. For brevity, we will refer to these
algorithms as Joint Segmentation algorithms (JS-algorithms).
Among the proposed JS-algorithms, we find methods that use a preprocessing step
to obtain segmented input data and methods that directly work on the original LRRs.
Table I reports a summary of some JS-algorithms for which a software implementation
is available. In cghMCR [9] a preprocessing step is used to obtain smoothed LRRs.
Smoothed data are then used to distinguish between normal and altered probes by a
percentile-based approach. Finally, cghMCR returns the regions found aberrant at least
in 75% of the samples. GISTIC [10] and JISTIC [11] also need smoothed LRRs: they
use smoothed data to compute for each probe a statistic representing the strength of the
aberration. This statistic is then used in a conservative permutation test to assess the
statistical significance of regions and finally CNAs that have a high evidence to be sites
of driver mutations are extracted by an iterative procedure known as peel-off that repre-
sents the main difference between GISTIC and JISTIC. GAIA [12] is very similar in spirit
to GISTIC and JISTIC, indeed, it also uses a conservative permutation test, but GAIA
uses as input a discrete representation of the observed LRRs, so that it can distinguish
between normal and aberrant probes. GAIA exploits this discrete data representation
to obtain information on the degree of homogeneity between adjacent probes, so that,
peel-off procedure can take in account both statistical significance and within-sample
homogeneity. Also pREC-A and pREC-S [13] use a preprocessing step but, differently
to other approaches, this step is used to compute a probability of alteration associated
to each probe and not a smoothed or discretized representation of the LRRs. These
probabilities are used in a Hidden Markov Model (HMM) to compute the joint probabil-
A VARIATIONAL PIECEWISE SMOOTH MODEL FOR IDENTIFICATION ETC. 103
ities of alteration for adjacent probes, in particular pREC-A and pREC-S use the HMM
to estimate the probability that consecutive probes belong to the same aberrant region.
The use of segmented data has been criticized because of the potentially loss of infor-
mation that it entails when input data are strongly affected by noise [14] and, in addition,
there is no possibility to avoid the propagation of the error from the preprocessing to
the rest of the downstream analysis [13]. To overcome these problems JS-algorithms,
directly working on the original LRRs, have been proposed. In BSA [15], segmenta-
tion and copy number assignment are simultaneously performed by using an hierarchical
Bayesian model. BSA sequentially detects CNAs based on the assumption that obser-
vations for different subjects in different genomic positions are independent conditional
on the boundaries. Also GADA [16] works on the original LRRs. GADA performs a
decomposition of the observed LRR into three components: the change in hybridization
due to altered copy number, the reference hybridization intensity for non-aberrant probes
and the noise component modeled as a zero-mean Gaussian process. GADA is based on
the assumption that copy number hybridization component can be approximated as a
piecewise constant (PWC) function and it uses an expectation maximization framework
to jointly estimate all three components. KCsmart [17] separates the original LRRs in
positive and negative values so that they can be separately summarized across the sam-
ples. Finally a smoothed estimation of CNAs is obtained by using a flat top Gaussian
kernel function. A different approach was proposed in CNAnova [18], indeed, it assumes
that the dataset is composed by a set of cancer samples and by a set of normal reference
samples. Based on this assumption and starting from the observed LRRs it computes the
distributions of the F - and t-statistics by using the one-way analysis of variance (one-way
ANOVA). These distributions are used to detect CNAs.
Here we describe a new JS-algorithm (VegaMC) that does not need of a preprocessing
step and jointly analyses copy number data. The proposed approach extends a previ-
ously published segmentation algorithm (Vega [8]) so that more than one sample can be
analyzed and recurrent CNAs can be detected. VegaMC is based on an efficient image
segmentation model known as Mumford and Shah model [19] where the PWC assump-
tion is used to define a functional where both accuracy and parsimony of the boundaries
are considered. Segmentation is performed by minimizing this functional with a greedy
region growing approach where the sequence of the regularization parameters is identified
by a data-drive heuristics. The difference between VegaMC and Vega is on the energy
functional: in Vega the functional is defined on a scalar function, while in VegaMC this
functional is defined on a vector-valued function whose components are different channels
(each channel models an aCGH sample). We applied VegaMC on a recently published
aCGH dataset of gastrointestinal stromal tumor composed by 25 samples. Current knowl-
edge about this tumor has been used to validate the performance of VegaMC showing
the ability of the proposed approach in detection of well-known aberrant cytobands.
The paper is organized as follows, the next section reports the datails of the adopted
method and the corresponding minimization algorithm, whereas the section of results
reports the obtained segmentation on real data.
2. – Method
This section is structured as follows: first we describe the Mumford and Shah model
which represents the basis of the proposed approach, then we provide a detailed descrip-
tion of VegaMC.
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2.1. Mumford and Shah Model . – In their original work, Mumford and Shah [19] in-
troduced the basic properties of variational models for computer vision. The aim of these
models was to provide a set of mathematical foundations for appropriate decomposition
of the domain Ω of a function uo : Ω → Rn (i.e. an multichannel image) into a set of
disjoint connected components Ωi:
Ω = Ω1 ∪ Ω2 ∪ . . .Ωn,
such that the function uo varies smoothly within each connected component Ωi and
uo varies discontinuously across the boundary Γ between different Ωi. Therefore, the
decomposition (segmentation) problem may be viewed as seeking of mathematical models
to define and compute optimal approximations of uo by piecewise smooth functions. To
this purpose, Mumford and Shah proposed the minimization of the following functional:
(1) E(u,Γ) = α
∫
Ω
(u− uo)2dx dy +
∫
Ω\Γ
|  u|2dx dy + λ|Γ|,
where α and λ are two non-negative parameters weighting the different terms in the
energy: the first term requires that u approximates uo, the second term takes in account
the variability of u within each connected component Ωi and the third term penalizes
complex solutions in terms of the length of the boundaries |Γ|. A special case of eq. (1)
is obtained when the approximation u of the signal uo is considered to be a piecewise
constant (PWC) function (u constant within each connected components Ωi). For this






(uo − ui)2dx dy + λ|Γ|.
It is easy to prove that the minimum for this model can be obtained by posing ui as
the mean of uo within of each connected component Ωi. Analysing the functional (2),
we can observe that the first term takes in account the error in the approximation of uo,
while the second term penalizes complex segmentations, thence this functional represents
a compromise between the accuracy of the approximation and the parsimony of the
boundaries. It is important to notice that the resulting segmentation depends on the
scale parameter λ, indeed it determines the amount of computed regions: when λ is
small many boundaries are allowed so the resulting segmentation will be fine, while as λ
increases the segmentation will be coarser and coarser.
2.2. VEGA Multi-Channel (VegaMC). – For a better comprehension of the aim of
the proposed approach consider the situation depicted in fig. 1 which shows the LRRs
of 4 samples. In this dataset we can distinguish 5 regions where, in agreement with the
Mumford and Shah model, in each region the LRRs (the function uo) varies smoothly
within each of them and varies discontinuosly across the boundaries. For non aberrant
probes LRR = 0 is expected (red line) and deviations from this value are indicator of
possible mutations. In the example depicted in fig. 1 we found 3 non aberrant regions
(R1, R3 and R5) and two possible aberrant regions (R2 and R4). Aim of VegaMC is the
identification of these regions by a joint analysis of all available samples.
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Fig. 1. – Example of aCGH dataset composed by 4 samples. The red line indicates the value 0,
which represents the LRR expected for non-aberrant probes. The dataset contains 5 different
regions R1, . . . , R5 delimited by vertical green lines.
2.2.1. The Model. Let m and n be the number of observed samples and the number
of probes observed for a chromosome respectively and let D ∈ Rmn be the data matrix
where the element Dij ∈ D contains the LRR observed on the j-th probes of the sample
i, then we define a segmentation S of D as a set of ordered positions (breakpoints)
partitioning the columns of D into M connected regions R = {R1, · · · , RM}. Here we use
the 1-dimensional version of the piecewise constant Mumford and Shah functional, in this
case the length of the boundaries between regions has no influence on the segmentation,






(uo − ui)2dx dy + λM.
Note that we are considering that uo is a vector-valued function characterized by
several channels, where each channel represents a different sample. Optimal segmentation
must be chosen among the 2n possible solutions. In aCGH data we have a resolution
that provides observations for more than 1 million of probes, so brute force algorithms
cannot be used and heuristic strategies must be applied. Here we use a greedy procedure
for minimization of (3).
2.2.2. Minimization Process. In order to compute the minimization of (3) we use a
region growing process where small adjacent regions are progressively merged to create
larger ones. In this way use a pyramidal algorithm that moves from fine to coarse
segmentations. Given two adjacent regions Ri and Rj the merging criterion used in the
minimization process is:
(4) E(u,Γ \Ri ∪Rj)− E(u,Γ)) = |Ri| |Rj ||Ri|+ |Rj | ‖ui − uj‖
2 − λ,
where Ri, Rj ∈ R with i = j, |Ri| is the length of the i-th region and ‖ · ‖ represents the
weighted L2 norm. Following a greedy procedure, the minimization process starts with
a segmentation having n regions each for each probe and in each step the pair of regions
that yields the best score are merged into a single region. In particular, given a fixed
value of λ, the algorithm iteratively looks for the pair of adjacent regions for which the
criterion in (4) is as negative as possible. If no pair of regions having negative value of (4)
exists, then the value of λ is increased. The resulting method is considered a multiscale
algorithm [20] where the value of λ represents the scale: as λ grows the segmentation
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gets coarser. The algorithm stops when the maximum value of the scale parameter is
reached. The sequence of values of this parameter is called λ-schedule by analogy with
temperature schedule of simulated annealing.
2.2.3. λ-schedule. λ-schedule is the sequence of λ used in the minimization process.
Careful selection of λ-schedule is fundamental to produce a “good” segmentation. From




|Ri−1|+ |Ri| ‖ui−1 − ui‖
2.
Given a fixed value λ representing the current value for the scale parameter in the
minimization process, two adjacent regions are merged if the respective cost λˆi < λ.
If no adjacent regions satisfy this inequality, then no merging is allowed and, in order
to continue in the minimization process, a new value for λ must be chosen. Here, as
in Vega, the next scale parameter value of the λ-schedule is chosen as the smallest λˆi
(plus a positive constant close to zero). By using this update rule new region merges are
allowed, so the region growing process will be composed by fine merging operations. In
this way the algorithm follows a greedy strategy where the selection of the next λˆ within
the λ-schedule represents the greedy choice.
3. – Results
We tested VegaMC on a Gastrointestinal Stromal Tumor (GIST) aCGH dataset.
GISTs are the most common mesenchymal tumors of the gastrointestinal tract. We used
the data published by [4] where 25 fresh tissue specimens of GISTs were collected and
hybridized by Affymetrix Genome Wide SNP 6.0 (GEO identifier GSE20710). Raw data
were preprocessed by PennCNV tool [21] obtaining the LRR for about 1.6 millions of
probes. In order to investigate the performances of VegaMC we used some well-known cy-
togenetic aberrations characterizing GIST. In particular, deletions of KIT and PDGFRA
genes (located in cytoband 4q12) were identified as important for tumor phenotype in
GIST, and their presence correlates with benefit from target therapy [22]. In addition,
loss of cytobands 14q11.2, 22q12.2 and 22q13.31 appears to play an important role in
early stage of tumor formation and in late tumor progression [23,24] and gains of 7p11.2
and 12q15 were confirmed by in situ hybridization [25]. Cytogenetic losses of 1p36.23,
9p21.3, 14q23.1, 13q14.3 and gain of 5q35.3 have also been related with GISTs [26,4].
The list of the considered cytogenetic aberrations is reported in table II, where in order
to distinguish between loss and gain we use the following rule: Let μ be the vector of the
mean for a region, then the correspondent CNA is considered a loss if ‖μ‖ < −0.2 and a
gain if ‖μ‖ > 0.2. These thresholds reflect the suggestions reported in Vega [8]. The first
observation is on the number of identified aberrant cytobands: on a total of 147 aberrant
cytobands 111 were identified as losses and 37 as gains. This confirmed the results of the
investigation of Chen et al. [27]: in GIST losses were more common than gains. From
table II we can see that VegaMC was in agreement to the biological knowledge on 75%
of the considered cytobands. In addition, we can notice that the weighted mean seems to
be a good index to summarize the possible state (loss, normal and gain). Indeed, in each
corrected evaluation the biological knowledge on the kind of the aberration is confirmed.
VegaMC did not detect aberrations for 1p36.23 (‖μ‖ = −0.03), 12q15 (‖μ‖ = 0.01) and
22q12.2 (‖μ‖ = −0.11) cytobands.
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Table II. – List of well-known aberrant cytobands in GIST. For each cytoband we report the
expected alteration (loss, gain) and the overlapped target genes with the respective descriptions.
For each cytoband we also report the results of VegaMC in terms of weighted mean and assigned
alteration.
(Cytoband) Expected Computed (Target genes) Ref.
alteration ‖μ‖ alteration
1p36.23 loss −0.03 normal ENO1 [23]
4q12 loss −0.22 loss KIT [22]
4q12 loss −0.22 loss PDGFRA [22]
5q35.3 gain 0.21 gain GNB2L1 [4]
7p11.2 gain 0.31 gain - [25]
9p21.3 loss −0.24 loss CDKN2A, CDKN2B [26]
12q15 gain 0.01 normal - [25]
13q14.3 loss −0.26 loss INTS6 [4]
14q23.1 loss −0.26 loss PPM1A [4]
14q32.33 loss −0.34 loss PACS2 [23]
22q12.2 loss −0.11 normal NF2 [24]
22q13.31 loss −0.30 loss - [24]
4. – Conclusions
Biological studies highlighted the importance of CNAs in cancer development and
progression. Here we described a new algorithm that performs a joint analysis of copy
number data (VegaMC) so that a map of the common CNAs can be obtained. VegaMC
is based on a popular image segmentation model and it uses a functional that takes into
account accuracy and penalizes complex solutions. Minimization of the functional is per-
formed by a greedy multiscale process where a data-driven strategy is used to define the
stopping condition in terms of scale parameter. In order to perform a qualitative assess-
ment we used a recently published aCGH dataset. Results show the ability of VegaMC
in detection of well-known cytogenetic mutations. Results also suggest that accuracy can
be improved by a suitable choice of the threshold used to distinguish between normal
and aberrant chromosomal regions. Finally we want to debate about the algorithmic
complexity of VegaMC. Finally we want to debate about the algorithmic complexity of
VegaMC. In order to improve the performance of VegaMC, in the minimization process
we used an heap structure so that the overall complexity is O(n(m + log n)). This im-
plementation strategy allowed to VegaMC to run in about 4′30′′ on GIST dataset which
represents a very interesting execution time.
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